New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Brought to you by 
Edwards Lifesciences Corp.
https://www.edwards.com/gb
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Edwards Lifesciences Corp.
FDA Approves Two New Indications For Edwards’ Sapien 3 TAVR System
Sapien 3 is now indicated to treat failed right ventricular outflow tract conduits, surgical bioprosthetic pulmonary valves and transcatheter aortic valves.
Medtronic Launches Trial Of Tricuspid Version Of Intrepid Transcatheter Valve
The company is sponsoring an early feasibility trial of the Intrepid transcatheter valve replacement system for patients with severe tricuspid regurgitation.
Medtronic ‘Plays Offense’ Despite Pandemic Challenges, Q1 Results Provide Optimism
Medtronic’s revenue of $6.5bn in the first quarter of fiscal 2021 represents a 17% fall year-over-year, but it still beat analysts’ projections.
Edwards Beat Analysts' And Its Own Projections in Q2 As TAVR Volumes Recover
The company recorded $925m in revenue in the second quarter of 2020, exceeding the top end of its previous guidance, and expects to return to growth by the end of the year.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Monitoring Equipment & Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- CardiAQ Valve Technologies, Inc.
- CAS Medical Systems, Inc.
- Embrella Cardiovascular, Inc.
- Harpoon Medical, Inc.
- Percutaneous Valve Technologies, Inc.
- Valtech Cardio, Ltd.